| Issue | Title | |
| Vol 2, Issue 1 (2022) | PCR-based Approach for Determining the Genetic Risk Factors of Antipsychotic-Induced Metabolic Disorders | Abstract PDF (Eng) |
| K. O. Mironov, I. I. Gaponova, V. I. Korchagin, A. S. Esman, E. A. Dunaeva, V. A. Zhivotova, V. S. Dobrodeeva, N. A. Shnayder, N. G. Neznanov, R. F. Nasyrova | ||
| Vol 1, Issue 2 (2021) | Personalized approach to addiction care | Abstract PDF (Eng) |
| E. M. Krupitsky | ||
| Vol 1, Issue 1 (2021) | Personalized approach to antipsychotic-induced weight gain prognosis | Abstract PDF (Eng) |
| V. S. Dobrodeeva, A. K. Abdyrahmanova, R. F. Nasyrova | ||
| Vol 5, Issue 1 (2025) | Personalized approach to prediction and prevention of haloperidol-induced metabolic syndrome | Abstract PDF (Eng) |
| V. V. Grechkina, N. A. Shnayder | ||
| Vol 5, Issue 2 (2025) | Personalized Medicine in Neurology | Abstract PDF (Eng) |
| Diana V. Dmitrenko | ||
| Vol 3, Issue 1 (2023) | Personalized Methodological Approaches to the Issues of Monitoring the Effectiveness and Safety of Pharmacotherapy with Antiepileptic Drugs Based on Mobile Medicine Technologies | Abstract PDF (Eng) |
| V. V. Arkhipov, K. M. Mantserov | ||
| Vol 4, Issue 3 (2024) | Personalized Psychiatry and Neurology: Step by Step | Abstract PDF (Eng) |
| L. Yu. Panteleeva | ||
| Vol 1, Issue 2 (2021) | Personalized psychiatry: achievements and prospects | Abstract PDF (Eng) |
| O. V. Limankin | ||
| Vol 1, Issue 2 (2021) | Perspectives of personalized approach to prevention and treatment of anticonvulsant-induced osteoporosis via action on vitamin D exchange and VDR expression | Abstract PDF (Eng) |
| E. A. Dontseva, V. V. Trefilova, T. E. Popova, M. M. Petrova, M. Al-Zamil | ||
| Vol 3, Issue 2 (2023) | Pharmacogenetic Factors of Clozapine-Induced Metabolic Syndrome | Abstract PDF (Eng) |
| A. K. Khasanova | ||
| 81 - 90 of 129 Items | << < 4 5 6 7 8 9 10 11 12 13 > >> | |












